ARS Pharmaceuticals Inc (SPRY)
8.93
+0.10
(+1.13%)
USD |
NASDAQ |
May 22, 16:00
8.92
-0.01
(-0.11%)
After-Hours: 20:00
ARS Pharmaceuticals Price to Book Value: 3.861 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 3.822 |
| May 20, 2024 | 3.978 |
| May 17, 2024 | 3.908 |
| May 16, 2024 | 3.939 |
| May 15, 2024 | 3.844 |
| May 14, 2024 | 3.887 |
| May 13, 2024 | 3.848 |
| May 10, 2024 | 3.783 |
| May 09, 2024 | 3.809 |
| May 08, 2024 | 3.921 |
| May 07, 2024 | 4.099 |
| May 06, 2024 | 4.090 |
| May 03, 2024 | 4.22 |
| May 02, 2024 | 4.094 |
| May 01, 2024 | 4.038 |
| April 30, 2024 | 3.766 |
| April 29, 2024 | 3.722 |
| April 26, 2024 | 3.614 |
| April 25, 2024 | 3.502 |
| April 24, 2024 | 3.575 |
| April 23, 2024 | 3.667 |
| April 22, 2024 | 3.542 |
| April 19, 2024 | 3.654 |
| April 18, 2024 | 3.641 |
| April 17, 2024 | 3.908 |
| Date | Value |
|---|---|
| April 16, 2024 | 3.960 |
| April 15, 2024 | 3.986 |
| April 12, 2024 | 3.891 |
| April 11, 2024 | 3.986 |
| April 10, 2024 | 3.999 |
| April 09, 2024 | 4.025 |
| April 08, 2024 | 4.284 |
| April 05, 2024 | 4.258 |
| April 04, 2024 | 4.111 |
| April 03, 2024 | 4.055 |
| April 02, 2024 | 4.003 |
| April 01, 2024 | 4.085 |
| March 28, 2024 | 4.274 |
| March 27, 2024 | 4.165 |
| March 26, 2024 | 4.182 |
| March 25, 2024 | 3.818 |
| March 22, 2024 | 3.617 |
| March 21, 2024 | 3.764 |
| March 20, 2024 | 3.638 |
| March 19, 2024 | 3.538 |
| March 18, 2024 | 3.814 |
| March 15, 2024 | 3.827 |
| March 14, 2024 | 3.760 |
| March 13, 2024 | 3.760 |
| March 12, 2024 | 3.535 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.123
Minimum
Sep 20 2023
4.284
Maximum
Apr 08 2024
2.643
Average
2.619
Median
Jul 14 2023
Price to Book Value Benchmarks
| KalVista Pharmaceuticals Inc | 5.586 |
| Phathom Pharmaceuticals Inc | -- |
| Vera Therapeutics Inc | 5.876 |
| Nuvalent Inc | 6.678 |
| CEL-SCI Corp | 4.922 |
Price to Book Value Related Metrics
| Price | 8.93 |
| Earnings Yield | -5.83% |
| Market Cap | 865.28M |